COEP - Coeptis Therapeutics Holdings, Inc.
16.4
0.190 1.159%
Share volume: 111,929
Last Updated: 04-24-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.22%
PREVIOUS CLOSE
CHG
CHG%
$16.21
0.19
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 08-16-2024 | 08-16-2024 | 11-13-2024 | 03-27-2025 | 05-14-2025 | 11-13-2025 | 03-19-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 62.874 K | 237.441 K | 862.049 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 45.156 K | 45.155 K | 45.157 K | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 17.718 K | 192.286 K | 816.892 K | |
| nan% | nan% | nan% | 985.26% | 324.83% | ||||
| Operating expenses | 2.227 M | 1.502 M | 1.416 M | 1.082 M | 2.681 M | 1.851 M | 1.892 M | |
| Selling general and admin | 1.450 M | 1.104 M | 604.377 K | 737.964 K | 2.595 M | 1.263 M | 1.579 M | |
| Research and development | 777.069 K | 398.817 K | 811.784 K | 343.878 K | 86.659 K | 587.279 K | 312.903 K | |
| Total expenses | 2.922 M | 2.828 M | 2.142 M | 2.162 M | 4.075 M | 2.669 M | 2.805 M | |
| -3.23% | -24.27% | 0.95% | 88.45% | -34.49% | 5.09% | |||
| Operating income | -2.922 M | -2.828 M | -2.142 M | -2.162 M | -4.057 M | -2.477 M | -1.988 M | |
| Ebit | -2.801 M | -2.969 M | -1.778 M | -2.733 M | -3.349 M | -2.836 M | -1.135 M | |
| Pretax income | -3.001 M | -3.035 M | -1.829 M | -3.012 M | -3.421 M | -2.899 M | -1.623 M | |
| 1.13% | -39.75% | 64.68% | 13.59% | -15.26% | -44.01% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.001 M | -3.035 M | -1.829 M | -3.012 M | -3.421 M | -2.899 M | -1.623 M | |
| -1.13% | 39.75% | -64.68% | -13.59% | 15.26% | 44.01% |